UNSPSC 51432311: Imidapril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C20H27N3O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7NSF9GG1NU, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4s)- but more generally known as imidapril hydrochloride, which bears US NIH Compound Identifier 5485193.

UNSPSC 51432311 Imidapril hydrochloride is a Commodity code representing a specific pharmaceutical product, but state and local procurement activity under this code shows little relevant recent engagement. The single recent opportunity on record—the City of Tampa's sealed bid for Advanced Life Support Medications (Solicitation 26P00188)—does not include imidapril hydrochloride among its line items. Tampa Fire Rescue's April 2026 solicitation specified labetalol HCI, epinephrine, adenosine, and diltiazem for emergency medical transport use, representing a mismatch between the code's nominal product scope and the work actually being bought. State and local procurement under pharmaceutical Commodity codes typically spans emergency medications, chronic-disease therapeutics, and preventive-care drugs purchased by health departments, fire and rescue services, correctional facilities, and school districts for clinical deployment or on-site dispensing.

The Tampa opportunity represents the geographic and issuing-body activity visible under this code in the current dataset. The City of Tampa's purchasing department issued the bid with a $40,000 estimated value and a one-year contract term with renewal and extension options, requiring delivery within ten calendar days of order and medications with a nine-month minimum shelf life at acceptance. A 5 percent bid discount applies to Small Local Business Enterprise participants, and vendors must submit OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. The mismatch between the code's pharmaceutical focus and the actual scope of recent solicitation activity suggests this code sees limited or misclassified utilization in state and local procurement channels, warranting direct outreach to fire rescue services, health departments, and emergency management offices to clarify current purchasing patterns and identify authentic procurement demand for this product.